Exploring the Genetic Architecture of Circulating 25-Hydroxyvitamin D

Genetic Epidemiology

Volumn 37, Issue 1, 2013, Pages 92-98

  Hiraki, Linda T ^a   Major, Jacqueline M ^b   Chen, Constance ^a   Cornelis, Marilyn C ^a   Hunter, David J ^a,c   Rimm, Eric B ^a,c   Simon, Kelly C ^a,c   Weinstein, Stephanie J ^b   Purdue, Mark P ^b   Yu, Kai ^b   Albanes, Demetrius ^b   Kraft, Peter ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Genome wide association; Heritability; Polygenic score; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC MARKER; GENETIC TRAIT; GENETIC VARIABILITY; GENOME ANALYSIS; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET B RADIATION;

ADULT; AGED; CASE-CONTROL STUDIES; CHOLESTANETRIOL 26-MONOOXYGENASE; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID HYDROXYLASES; VITAMIN D;

EID: 84871071783     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.21694     Document Type: Article

References (45)

1. Ahn J, Peters U, Albanes D, Purdue MP, Abnet CC, Chatterjee N, Horst RL, Hollis BW, Huang WY, Shikany JM and others. 2008. Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst 100(11):796-804.
2. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB and others. 2010. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19(13):2739-2745.
3. The ATBC Cancer Prevention Study Group. 1994. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 4(1):1-10.
4. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE. 2005. Plasma 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14(8):1991-1997.
5. Bush WS, Sawcer SJ, de Jager PL, Oksenberg JR, McCauley JL, Pericak-Vance MA, Haines JL. 2010. Evidence for polygenic susceptibility to multiple sclerosis-the shape of things to come. Am J Hum Genet 86(4):621-625.
6. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, Hennekens CH, Speizer FE. 1986. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123(5):894-900.
7. Daetwyler HD, Villanueva B, Woolliams JA. 2008. Accuracy of predicting the genetic risk of disease using a genome-wide approach. PLoS One 3(10):e3395.
8. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R and others. 2007. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087-1093.
9. Evans DM, Visscher PM, Wray NR. 2009. Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. Hum Mol Genet 18(18):3525-3531.
10. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL and others. 2010. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 172(1):10-20.
11. Giovannucci E. 2005. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2):83-95.
12. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 2008. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168(11):1174-1180.
13. Group TAS. 1994. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 4(1):1-10.
14. Hayes RB, Sigurdson A, Moore L, Peters U, Huang WY, Pinsky P, Reding D, Gelmann EP, Rothman N, Pfeiffer RM and others. 2005. Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res 592(1-2):147-154.
15. Holick MF. 2004. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80(6 Suppl):1678S-1688S.
16. Hollis BW. 1997. Quantitation of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282:174-186.
17. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. 1993. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 39(3):529-533.
18. Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD. 2001. Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. J Bone Miner Res 16(2):371-378.
19. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A and others. 2007. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870-874.
20. Koushik A, Kraft P, Fuchs CS, Hankinson SE, Willett WC, Giovannucci EL, Hunter DJ. 2006. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 15(12):2408-2417.
21. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S and others. 2010. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467(7317):832-838.
22. Machiela MJ, Chen CY, Chen C, Chanock SJ, Hunter DJ, Kraft P. 2011. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. Genet Epidemiol 35(6):506-514.
23. Maher B. 2008. Personal genomes: the case of the missing heritability. Nature 456(7218):18-21.
24. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A and others. 2009. Finding the missing heritability of complex diseases. Nature 461(7265):747-753.
25. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832-2838.
26. Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ, Vieth R, Sadovnick AD, Ebers GC. 2008. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88(2):441-447.
27. Pierce BL, Tong L, Kraft P, Ahsan H. 2012. Unidentified genetic variants influence pancreatic cancer risk: an analysis of polygenic susceptibility in the PanScan Study. Genet Epidemiol 36(5):517-524.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ and others. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
29. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256):748-752.
30. Qi L, Cornelis MC, Kraft P, Stanya KJ, Linda Kao WH, Pankow JS, Dupuis J, Florez JC, Fox CS, Pare G and others. 2010. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet 19(13):2706-2715.
31. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. 1992. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135(10):1114-1126; discussion 1127-36.
32. Shea MK, Benjamin EJ, Dupuis J, Massaro JM, Jacques PF, D'Agostino RB, Sr., Ordovas JM, O'Donnell CJ, Dawson-Hughes B, Vasan RS and others. 2009. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 63(4):458-464.
33. Signorello LB, Shi J, Cai Q, Zheng W, Williams SM, Long J, Cohen SS, Li G, Hollis BW, Smith JR and others. 2011. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLoS One 6(12):e28623.
34. Sinotte M, Diorio C, Berube S, Pollak M, Brisson J. 2009. Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89(2):634-640.
35. Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, Do R, Voight BF, Kraft P, Chen R, Kallberg HJ, Kurreeman FA and others. 2012. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 44(5):483-489.
36. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, Hankinson SE, Hutchinson A, Wang Z, Yu K and others. 2009. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 41(5):579-584.
37. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL and others. 2010. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376(9736):180-188.
38. Willer CJ, Li Y, Abecasis GR. 2010. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26(17):2190-2191.
39. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Hennekens CH, Speizer FE. 1987. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 316(19):1174-1180.
40. Witte JS, Hoffmann TJ. 2011. Polygenic modeling of genome-wide association studies: an application to prostate and breast cancer. OMICS 15(6):393-398.
41. Wjst M, Altmuller J, Braig C, Bahnweg M, Andre E. 2007. A genome-wide linkage scan for 25-OH-D(3) and 1, 25-(OH)2-D3 serum levels in asthma families. J Steroid Biochem Mol Biol 103(3-5):799-802.
42. Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR, Madden PA, Heath AC, Martin NG, Montgomery GW and others. 2010. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 42(7):565-569.
43. Yang J, Lee SH, Goddard ME, Visscher PM. 2011. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 88(1):76-82.
44. Zaitlen N, Kraft P. 2012. Heritability in the genome-wide association era. Hum Genet 131(10):1655-1664.
45. Zuk O, Hechter E, Sunyaev SR, Lander ES. 2012. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA 109(4):1193-1198.